Carta Healthcare

Carta Healthcare

Carta Healthcare launched in San Francisco to address a specific pain point in American hospital administration: turning unstructured clinical notes into the structured, auditable registries that determine reimbursement, quality ratings, and research eligibility. The founding team remains unnamed in available primary sources, though early backing came from Frist Cressey Ventures. The firm built its platform around a concept it calls Hybrid Intelligence, which layers internally trained AI models over an in-house team of more than 200 clinical abstractors whose collective clinical experience exceeds 200 years. The business spans two tightly coupled revenue streams. On the software side, its Voyager AI platform, Lighthouse AI-assisted abstraction module, and Navigator clinical-intelligence tool are deployed across a nationwide roster of health systems including Memorial Hermann, UNC Health, and Northern Arizona Healthcare. On the services side, those same hospitals can engage the firm's abstraction professionals for staff augmentation or outsourced registry work. The firm publishes case studies asserting that the combined model reduces abstraction costs by 50% or more and cuts registry turnaround times by up to 66%, with inter-rater reliability scores routinely reaching 98–99%. This is not pure SaaS—the labor component makes it operationally closer to a tech-enabled managed service. The firm claims 100% customer retention, a metric that matters in a market where hospital IT vendor churn is endemic but must be read as unaudited. In 2026, Carta Healthcare won an Artificial Intelligence Excellence Award for advancing clinical automation, according to its own website, and it publicly positions its 200-plus abstractors as a durable competitive advantage rather than a cost center to be automated away. No total deployment figure, headcount beyond the abstractor pool, or additional office locations appear in available primary sources. A genuine structural differentiator is the explicit, public refusal to separate software from labor. Most AI-in-healthcare companies promise to replace human chart review; Carta Healthcare's website and case studies argue that high-quality clinical data requires both, and that the clinical judgment of its abstractors is what keeps IRR scores near 99%. That hybrid architecture resists the pure-SaaS margin structure investors typically prize but aligns tightly with the compliance culture of large health systems. It also makes the firm harder to displace: ripping out the software means ripping out the people who run the registries.